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A B S T R A C T
This is a retrospective review of patients with advanced malignant neoplasms of the larynx treated with total laryng-
ectomy. 387 total laryngectomies for advanced squamous cell carcinoma of larynx performed in the period between 1995
and 2007 were analyzed. Primary total laryngectomy (PRT) was performed in 316 patients, while initial radiotherapy
radiotherapy (60–70 Gy) and concomitant chemotherapy (cisplatin-5 fluorouracil) with radiotherapy were applied in to-
tally 71 patients who later received salvage total laryngectomy (STL). All the laryngectomies were performed by four sur-
geons, using the same routine surgical technique. Postoperative clinical examination was made every three months dur-
ing five years. We documented the occurrence of: local and general complications, survival rate, residual and recurrent
disease, lymph node metastasis, and other changes. Salvage total laryngectomy after previous radiotherapy (STL-pRT)
and after chemoradiotherapy (STL-pCTRT) caused more frequent local complications than primary total laryngectomy
(PTL). TNM stage and localization of primary laryngeal tumor had significant influence on five year survival rate. It
amounted: 61.4% for PTL, 52.6% for STL-pCTRT, and 48.5% for STL-pRT. Incomplete response to initial treatment pro-
duced low survival rate. Salvage total laryngectomy caused more frequent local complications, especially after chemo-
radiotherapy whan compared to primary laryngectomy. Survival rate was increased when chemotherapy is added to ra-
diotherapy. Five year survival rate depended on TNM stage and localization of primary tumor.
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Introduction
Recent advances in surgical techniques and multidis-
ciplinary treatment procedures have improved the man-
agement of malignant neoplasms of upper aerodigestive
tract. However, these malignancies have high recurrence
rates, low survival, and significant alterations in speech
and swallowing function. Thus, carefully consideration
of morbidity and outcome within the context of the pa-
tient’s medical condition is needed1,2. Larynx preserva-
tion approach using chemoradiotherapy for potential
preservation of voice and swallowing and with similar
survival rate to primary laryngectomy was proposed. Sal-
vage laryngectomy is used for failure of treatment, when
persistent disease or when biopsy proven recurrent tu-
mor are present. However, salvage surgery is accompa-
nied with significantly more frequent complications1,3.
Complications after total laryngectomy can be local (fis-
tula, infection, chyle leak, carotid rupture, and flap ne-
crosis), and general (pulmonary, myocardial infarction,
metabolic, urinary infection), as well as airway and swal-
lowing difficulties. They significantly affect morbidity,
hospitalization and costs of the treatment4–6. Random-
ized comparison of primary and salvage laryngectomy is
very rare in medical references. Adequate conclusions
are difficult because of different surgical techniques, in-
sufficient number of cases, and many variables that are
influential4,7,8.
A retrospective review of the patients with malignant
neoplasms of larynx treated with primary and salvage to-
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tal laryngectomy is reported to compare the results, com-
plications and factors of outcome of the treatment. This
study was conducted on a large number of patients in a
single institution and uniform treatment protocol.
Patients and Methods
In the period between 1996 and 2007 we performed
387 total laryngectomies for advanced squamous cell car-
cinoma of larynx. Primary total laryngectomy (PRT) was
applied in 316 patients, while in 38 patients initial radio-
therapy (60–70Gy), and in 33 patients chemotherapy
(cisplatin-5 fluorouracil) with radiotherapy were intro-
duced becauce of refusal of primary surgery, and they
later received salvage total laryngectomy (STL).
ENT examination, CT of the neck, panendoscopy
with biopsy, as well as laboratory, cardiologic and pulmo-
nary examination were performed preoperatively. Stag-
ing was made with the help of computed tomography (ex-
tent of disease at the primary site, status of lymph nodes
in the neck, and evaluation for metastatic disease). Age,
sex, medical comorbidity, smoking and drinking habit
were also documented.
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TABLE 1
LARYNGEAL CARCINOMA PARAMETERS, STATUS, SURGERY, AND COMPLICATIONS (NS=NON SIGNIFICANT)
PARAMETER
PTL STL-pRT STL-pCTRT TOTAL
P
No % No % No % No %
Site
supraglottic 96 30.4 20 52.6 15 45.4 131 33.9
glottic 170 53.3 10 26.3 10 30.3 190 49.1 NS
transglottic 50 15.3 8 21.14 8 24.3 66 17.0
cT stage
T1 0 0 0 0 0 0 0 0
T2 0 0 5 13.2 0 0 5 1.3 NS
T3 184 58.2 15 390.5 22 66.7 221 57.1
T4 132 41.8 18 47.3 11 33.3 161 41.6
cN stage
N0 23 7.3 3 7.9 0 0 26 6.7
N1 81 25.6 4 10.5 1 3.0 86 22.2 NS
N2 127 40.2 20 52.6 22 66.7 169 43.7
N3 85 26.9 11 28.8 10 30.3 106 27.4
cTNM
stage I 0 0 0 0 0 0 0 0
stage II 0 0 3 7.9 0 0 3 0.8 P<0.05
stage III 81 25.6 4 10.5 2 6.1 87 22.5
stage IV 235 74.4 51 88.6 31 93.9 297 76.7
Comorbidity
Yes 16 5.1 21 28.9 3 8.3 30 7.8 P<0.01
No 300 94.9 27 71.1 30 91.7 357 92.2
Reconstruction
No 316 100 36 94.7 29 87.9 381 98.5 NS
Yes 0 0 2 5.3 4 12.1 6 1.5
Dissection
RND 95 30.0 12 31.6 22 65.7 129 33.3
SND 162 51.3 22 57.9 11 33.3 195 50.4 NS
No 59 18.8 4 10.5 0 0 63 16.3
Infection
No 277 87.6 30 78.8 20 60.6 327 84.5 P<0.01
Yes 39 12.3 8 21.1 13 39.4 60 15.5
Fistula
No 279 88.3 30 78.9 23 69.7 332 85.8 P<0.01
Yes 37 11.7 8 21.1 10 30.3 55 14.2
Swallow dif.
No 298 94.3 26 68.4 24 72.7 348 89.9 P<0.01
Yes 18 5.7 12 31.6 9 27.3 39 10.1
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All the laryngectomies were performed by four sur-
geons, using the same routine surgical technique. Briefly,
pharynx was closed linearly or in T shape, with 3-0 Vicryl
single stitches, muscular reinforcement was made using
the same material, and nasogastric tube was used for 7
days.
Postoperative clinical examination was performed ev-
ery three months during five years. Local and general
complications, survival rate, residual and recurrent dis-
ease, lymph node metastasis, and other changes were
noted. Suspected residual or recurrent disease was con-
firmed by endoscopy and biopsy.
c2-test was used to find out the differences between
the groups of the patients (p value less than 0.05 con-
firmed the presence of a statistically significant differ-
ence).
Results
Age of the patients was under 50 years in 54.7%,
while the rest were older than 50 years. Male patients
were present in 84.2%. Smoking habit was reported in
91.5%, and drinking habit in 88.6%. There was no statis-
tically significant difference between the groups of treat-
ment.
The most frequent tumor site was glottic with 49.1%,
followed by supraglottic in 33.9%, and subglottic or trans-
glottic localization in 17.0%. T3 stage (57.1%) was more
frequent than T4 stage of the disease. N2 stage predomi-
nated with 43.7%, while N3 and N1 were less frequent.
Only 6.7% of patients presented without affected neck
nodes. Thus, 76.7% of the patients were in the stage IV,
and only 22.5% in the stage III. No significant differences
for all these parameters between PTL, STL-pCT, and
STL-pCTRT groups were found (Table 1).
Medical comorbidity was verified in 7.8% of patients
with laryngeal cancer, and it was statistically more fre-
quent in the group of the patients that were treated by
primary radiotherapy.
The interval between the initial treatment and sal-
vage laryngectomy ranged from two to 43 months (me-
dian 5.1 months). Surgical complications for PTL and
STL were absent. The mean length of hospitalization af-
ter primary total laryngectomy was 12.4 days, compared
to 18.5 days after salvage surgery. Nasogastric tube was
in place for average 16.5 days after STL.
Selective neck dissection was the most frequent type
of dissection performed (50.4%), without significant dif-
ference between the groups. The biggest number of radi-
cal neck dissections was performed in STL-pCTRT group.
Neck dissection specimens after radiotherapy were posi-
tive for metastatic cancer in 57,7%, while after chemo-
radiotherapy in 73,5%, which correlated to the N stage.
Pectoral myocuteneous flap was mainly used for re-
construction in STL-pCTRT group, and less frequent in
the STL-pRT group, while no reconstruction was needed
after primary laryngectomy.
Wound infection was confirmed in 19.4%, and pharyn-
gocutaneous fistula in 16.3%. Statistically significant in-
crease of local complications in salvage laryngectomy
group was found. Patients with laryngeal cancer receiv-
ing chemoradiotherapy developed postlaryngectomy fis-
tula twice more frequently than for primary laryngec-
tomy. The mean time for spontaneous closure of fistulas
was 25±3 days. Totally 88.4% of fistulas closed spontane-
ously, with local care and specific antibiotic treatment.
Spontaneous closure of fistulas after radiotherapy was
verified in 81.2%, while after previous chemoradiothe-
rapy it was only in 67.7%. The persistent fistulas were
closed after one month by local flap, or rarely using pec-
toral myocutaneous flap. Swallowing problems were sig-
nificantly more frequent in STL groups. Carotid artery
rupture was very rare in laryngeal cancers (0.5%). Imme-
diate surgical ligation and musculocutenous flaps for cov-
ering of exposed vessels were performed in such cases.
Airway and systemic complications were not significant-
ly different between the groups.
Five year follow-up of the patients was complete in
90.1% of the patients with advanced laryngeal cancer.
The overall survival rate after total laryngectomy was
59.5%. TNM stage of the disease was very significant fac-
tor for the survival, so for T4 it was 55.0% (Figure 1).
Similar results were present when N stage was analyzed
(Figure 2). Stage IV of the disease gave five years sur-
vival in 56.0% (Figure 3). The worst survival rate was
verified for transglottic and subglottic cancer (Figure 4).
The survival rate of primary was significantly better
amounting: 61.4% for PTL, 52.6% for STL-pCTRT, and
48.5% for STL-pRT (Figure 5). Five years survival rate
for patients who responded completely to initial treat-
ment was favourable. After STL-pCTRT it was 68.4%,
and after STL-pRT 63.2%. Incomplete response to initial
treatment had five year survival rate totally in about
only one third of the patients (Figure 6).
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Fig. 1. Five year survival rate for laryngeal carcinoma after total
laryngectomy depending on the t stage (Kaplan Meier).
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Discussion
Laryngeal preservation means larynx in place, no re-
sidual tumor, no tracheotomy and no feeding tube. Also,
preservation of function is more important to the pa-
tients than just anatomic integrity of the larynx8,9. Multi-
-institutional studies in the United States support organ
preservation for management of the primary site in head
and neck squamous cell carcinoma. However, large study
of treatment of laryngeal cancer in the US confirmed
higher survival when patients had primary laryngecto-
my10. Also, none of the nonsurgical approaches to treat-
ment of laryngopharyngeal cancer gave a better survival
than initial radical surgery11,12. There are insufficient
data on salvage laryngeal surgery after initial radioche-
motherapy. Proper detection of tumor, determination of
surgical margins, adequate resection, and complication
rate, are difficulties associated with salvage total laryng-
ectomy8,13. Postlaryngectomy pharyngocuteneous fistula
is found in the range from 3% to 65%. Metacentric study
on postlaryngectomy fistula denoted the significance of:
preoperative hemoglobin, prior tracheotomy, previous
radiotherapy and neck dissection. There are insufficient
data to confirm the importance of suture material, anti-
biotics, positive surgical margins, pharyngeal myotomy,
blood transfusion and type of radiotherapy14–16. Some au-
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Fig. 2. Five year survival rate for laryngeal carcinoma after total
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Fig. 3. Five year survival rate for laryngeal carcinoma after total
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Fig. 4. Five year survival rate for laryngeal carcinoma after total
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Fig. 5. Five year survival rate for laryngeal carcinoma after total
laryngectomy depending on the previous treatment (PTL=primary
total laryngectomy, STL-pRT=salvage total laryngectomy after
radiotherapy, STL-pCTRT=salvage total laryngectomy after chemo-
radiotherapy) (Kaplan Meier).
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thors do not place nasogastric tubes, and start oral feed-
ing after three days from the surgery17,18. More frequent
fistulas after radiotherapy, especially when bigger fields
and doses were used were found. Nowadays, the reported
rate is slightly less, probably because of advances in ra-
diotherapy and surgery, as well3,13,19. Chemotherapy was
important factor that increased wound complications in
treated patients, and the rate is even bigger when radio-
therapy is added20. Independent risk factors for survival
in this study were: advanced clinical stage of the disease,
tumor localization, incomplete response to initial ther-
apy and previous therapy. Stage IV caused low survival of
the patients. Transglottic and subglottic localization were
particularly associated with low survival that was caused
by local propagation and advanced neck stage. Salvage
total laryngectomy produced worse results than for pri-
mary surgery. The addition of chemotherapy to radio-
therapy significantly improved the outcome. Since the
differences in the stage of the disease between the groups
were not significant, these results imply the advantage of
primary surgery. CT, MRI and ultrasound have limita-
tions in detecting recurrent carcinoma, especially after
salvage surgery. The reduction of the interval from initial
therapy to salvage surgery could improve the survival
rate20–23.
Conclusion
Primary total laryngectomy (PTL) for laryngeal carci-
noma was associated with pharyngocutenoues fistula in
11.7%, while salvage total laryngectomy after previous
radiotherapy (STL-pRT) had fistula in 21.1%, and after
chemoradiotherapy (STL-pCTRT) in 30.3%. Salvage to-
tal laryngectomy was also accompanied by increase of
wound infection and swallowing problems. Five year sur-
vival rate was significantly influenced by TNM stage and
localization of primary laryngeal tumor, amounting: 61.4%
for PTL, 52.6% for STL-pCTRT, and 48.5% for STL-pRT.
Incomplete response to initial treatment caused survival
rate only 37.5% after chemoradiotherapy and 34.2% after
radiotherapy.
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Fig. 6. Five year survival rate for laryngeal carcinoma after total
laryngectomy depending on the response to initial therapy (+pRT=
complete reaction after radiotherapy, -pRT=incomplete reaction
after radiotherapy, +pCTRT= complete response after chemora-
diotherapy, -pCTRT= incomplete response after chemoradiothe-
rapy) (Kaplan Meier).
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DOPRINOSE]I FAKTORI, KOMPLIKACIJE I STUPANJ PRE@IVLJAVANJA PRIMARNE I
SEKUNDARNE TOTALNE LARINGEKTOMIJE KOD UZNAPREDOVALOG KARCINOMA LARINKSA
S A @ E T A K
Provedena je retrospektivna analiza pacijenata sa uznapredovalim malignim tumorom grkljana tretiranih totalnom
laringektomijom. Ukupno 387 totalih laringektomija kod uznapredovalih carcinoma grkljana na~injeno je u periodu od
1995 do 2007. godine. Primarna totalna laringektomija (PTL) obavljena je u 316 pacijentas, dok je inicijalna radio-
terapija (60–70 Gy) i konkomitantna kemoterapija (cisplatin-5 fluorouracil) sa radioterapijom primenjena u 71 paci-
jenta, a koji su kasnije tretirani sekundarnom totalnom laringektomijom (STL). Sve laringektomije obavila su ~etiri
kirurga primenom klasi~ne kirur{ke tehnike. Postoperativni klini~ki pregled vr{en je svaka tri mjeseca tokom pet godi-
na. Dekumentirano je prisustvo: lokalnih i op}ih komplikacija, stupanj pre`ivljavanja, rezidualna i rekurentna bolest,
limfogene metastaze i druge promjene. Sekundarna totalna laringektomija poslije radioterapije (STL-pRT) i kemo-
terapije (STL-pCTRT) uvjetovala je ~e{}e lokalne komplikacije nego primarna totalna laringektomija (PTL). TNM sta-
dij i lokalizacija primarnog tumora grkljana imali su zna~ajan udio na petogodi{nje pre`ivljavanje. Ono je iznosilo:
61.4% za PTL, 52.6% za STL-pCTRT, kao i 48.5% za STL-pRT. Nekompletan odgovor na po~etni tretman dao je nizak
stupanj pre`ivljavanja. Sekundarna totalna laringektomija uvjetuje vi{e lokalnih komplikacija, posebno poslije kemo-
terapije, a u uporedbi sa primarnom totalnom laringektomijom. Stupanj pre`ivljavanja se pove}ava primjenom kemo-
terapije uz radioterapiju. Petogodi{nje pre`ivljavanje zavisi od TNM stadijuma i lokalizacije primarnog tumora.
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